|
1
|
Bieber T: Atopic dermatitis. N Engl J Med.
358:1483–1494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnes KC: An update on the genetics of
atopic dermatitis: scratching the surface in 2009. J Allergy Clin
Immunol. 125:16–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Habu Y, Seki S, Takayama E, Ohkawa T,
Koike Y, Ami K, Majima T and Hiraide H: The mechanism of a
defective IFN-gamma response to bacterial toxins in an atopic
dermatitis model, NC/Nga mice, and the therapeutic effect of
IFN-gamma, IL-12, or IL-18 on dermatitis. J Immunol. 166:5439–5447.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin H, He R, Oyoshi M and Geha RS: Animal
models of atopic dermatitis. J Invest Dermatol. 129:31–40. 2009.
View Article : Google Scholar
|
|
5
|
Shiohara T, Hayakawa J and Mizukawa Y:
Animal models for atopic dermatitis: are they relevant to human
disease? J Dermatol Sci. 36:1–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berke R, Singh A and Guralnick M: Atopic
dermatitis: an overview. Am Fam Physician. 86:35–42.
2012.PubMed/NCBI
|
|
7
|
Bersanetti PA, Park HY, Bae KS, Son KH,
Shin DH, Hirata IY, Juliano MA, Carmona AK and Juliano L:
Characterization of arazyme, an exocellular metalloprotease
isolated from Serratia proteamaculans culture medium. Enzyme Microb
Technol. 37:574–581. 2005. View Article : Google Scholar
|
|
8
|
Kwak J, Lee K, Shin DH, Maeng JS, Park DS,
Oh HW, Son KH, Bae KS and Park HY: Biochemical and genetic
characterization of arazyme, an extracellular metalloprotease
produced from Serratia proteamaculans HY-3. J Microbiol Biotechnol.
17:761–768. 2007.PubMed/NCBI
|
|
9
|
Kim IS, Kim MJ, Shin DH, Son KH, Park HY
and Lee JS: Arazyme inhibits cytokine expression and upregulates
skin barrier protein expression. Mol Med Rep. 8:551–556.
2013.PubMed/NCBI
|
|
10
|
Kim IS, Yang EJ, Shin DH, Son KH, Park HY
and Lee JS: Effect of arazyme on the lipopolysaccharide-induced
inflammatory response in human endothelial cells. Mol Med Rep.
10:1025–1029. 2014.PubMed/NCBI
|
|
11
|
Lee JS, Kim IS, Ryu JS, Kim JH, Kim JS,
Kim DH and Yun CY: The inhibitory effect of Duchesnea chrysantha
extract on the development of atopic dermatitis-like lesions by
regulating IgE and cytokine production in Nc/Nga mice. Phytother
Res. 26:284–290. 2012. View
Article : Google Scholar
|
|
12
|
Kim IS, Kim DH, Yun CY and Lee JS: A
(S)-(+)-decursin derivative,
(S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid
2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester,
attenuates the development of atopic dermatitis-like lesions in
NC/Nga mice. Mol Biol Rep. 40:2541–2548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Witter RF and Grubbs LM: An evaluation of
the Reitman-Frankel method for the determination of serum glutamic
oxalacetic transaminase. Clin Chim Acta. 13:524–527. 1966.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park JK, Jeong DH, Park HY, Son KH, Shin
DH, Do SH, Yang HJ, Yuan DW, Hong IH, Goo MJ, Lee HR, Ki MR,
Ishigami A and Jeong KS: Hepatoprotective effect of Arazyme on
CCl4-induced acute hepatic injury in SMP30 knock-out mice.
Toxicology. 246:132–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka A, Amagai Y, Oida K and Matsuda H:
Recent findings in mouse models for human atopic dermatitis. Exp
Anim. 61:77–84. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Romagnani S: Lymphokine production by
human T cells in disease states. Annu Rev Immunol. 12:227–257.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suto H, Matsuda H, Mitsuishi K, Hira K,
Uchida T, Unno T, Ogawa H and Ra C: NC/Nga mice: a mouse model for
atopic dermatitis. Int Arch Allergy Immunol. 120(Suppl 1): 70–75.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang EJ, Lee JS, Yun CY, Kim JH, Kim JS,
Kim DH and Kim IS: Inhibitory effects of Duchesnea chrysantha
extract on ovalbumin-induced lung inflammation in a mouse model of
asthma. J Ethnopharmacol. 118:102–107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luzina IG, Keegan AD, Heller NM, Rook GA,
Shea-Donohue T and Atamas SP: Regulation of inflammation by
interleukin-4: a review of “alternatives”. J Leukoc Biol.
92:753–764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamanaka K and Mizutani H: The role of
cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr
Probl Dermatol. 41:80–92. 2011. View Article : Google Scholar : PubMed/NCBI
|
